Fiducient Advisors’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$289K Buy
+1,500
New +$162K 0.04% 125

Other funds holding MRNA

Fiducient Advisors's MRNA Position: Q3 2026 in Review

Fiducient Advisors opened a new position in Moderna (MRNA) in Q3 2026: 1,500 shares worth $289K. The stake represents 0.04% of the portfolio and ranks #125 among its holdings.

1,044 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Fiducient Advisors held 1,500 shares of Moderna worth $289K as of Q3 2026.
  • Moderna was a new Fiducient Advisors position in Q3 2026.
  • Moderna made up 0.04% of Fiducient Advisors's portfolio in Q3 2026, its #125 holding.
  • 1,044 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Fiducient Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.